Inventor · disambiguated record
Klaus Linz
Also filed as: LINZ KLAUS
35 granted patents·44 pending applications·241 citations·filing 2004–2023
97Inventor score
Top patents by PatentIndex Score
79 records- 0196US7547707B2Spirocyclic cyclohexane compoundsGRUENENTHAL GMBH·Filed 2005·Granted Jun 16, 2009·40 cites·18 claims
- 0293US7799931B2Spirocyclic cyclohexane compoundsGRUENENTHAL GMBH·Filed 2009·Granted Sep 21, 2010·21 cites·17 claims
- 0392US8138187B2Substituted heteroaryl derivativesZEMOLKA SASKIA·Filed 2007·Granted Mar 20, 2012·34 cites·17 claims
- 0492US8053576B2Compositions containing spirocyclic cyclohexane compoundsGRUENENTHAL GMBH·Filed 2009·Granted Nov 8, 2011·15 cites·10 claims
- 0591US7951948B2Spirocyclic cyclohexane compoundsGRUENENTHAL GMBH·Filed 2010·Granted May 31, 2011·13 cites·18 claims
- 0691US7332519B2Spirocyclic cyclohexane compoundsGRUENENTHAL GMBH·Filed 2004·Granted Feb 19, 2008·57 cites·29 claims
- 0786US7977370B2(Hetero)aryl cyclohexane derivativesGRUENENTHAL GMBH·Filed 2009·Granted Jul 12, 2011·11 cites·9 claims
- 0884US8034936B2Spirocyclic cyclohexane compounds useful to treat substance dependencyGRUENENTHAL GMBH·Filed 2010·Granted Oct 11, 2011·5 cites·19 claims
- 0983US2023174540A13-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2023·Application pending·0 cites
- 1083US2023183184A13-(Carboxyethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2023·Application pending·0 cites
- 1182US10829480B23-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2019·Granted Nov 10, 2020·1 cites·27 claims
- 1282US10807988B23-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2019·Granted Oct 20, 2020·1 cites·29 claims
- 1382US10793556B28-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2019·Granted Oct 6, 2020·1 cites·30 claims
- 1482US9320729B2Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivativeGRUENENTHAL GMBH·Filed 2013·Granted Apr 26, 2016·5 cites·23 claims
- 1582US8293758B2Substituted spirocyclic cyclohexane derivativesZEMOLKA SASKIA·Filed 2009·Granted Oct 23, 2012·7 cites·9 claims
- 1682US2023174520A13-((Hetero-)Aryl)-Alkyl-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2023·Application pending·0 cites
- 1782US2023303573A13-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2022·Application pending·0 cites
- 1882US2023183222A18-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2023·Application pending·0 cites
- 1981US9862719B2Process or preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compoundsGRUENENTHAL GMBH·Filed 2015·Granted Jan 9, 2018·2 cites·6 claims
- 2079US8288406B2HydroxymethylcyclohexylaminesFRORMANN SVEN·Filed 2010·Granted Oct 16, 2012·9 cites·10 claims
- 2177US11311504B2Pharmaceutical composition comprising (1R,4R)-6′- fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano- [3,4,b ]indol] -4-amine and paracetamol or propacetamolGRUENENTHAL GMBH·Filed 2019·Granted Apr 26, 2022·1 cites·17 claims
- 2275US9320725B2Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoidGRUENENTHAL GMBH·Filed 2013·Granted Apr 26, 2016·2 cites·12 claims
- 2375US9120797B2Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compoundsHINZE CLAUDIA·Filed 2011·Granted Sep 1, 2015·3 cites·19 claims
- 2475US8288430B2Spiro(5.5)undecane derivativesZEMOLKA SASKIA·Filed 2009·Granted Oct 16, 2012·3 cites·7 claims
- 2574US8912226B2Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSARGRUENENTHAL GMBH·Filed 2013·Granted Dec 16, 2014·2 cites·18 claims
- 2674US2021188860A13-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2021·Application pending·0 cites
- 2774US2021179627A13-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2021·Application pending·0 cites
- 2874US2021214315A13-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2021·Application pending·0 cites
- 2974US2021179595A18-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2021·Application pending·0 cites
- 3073US2021179592A13-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2021·Application pending·0 cites
- 3172US10076510B2Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivativeGRUENENTHAL GMBH·Filed 2016·Granted Sep 18, 2018·1 cites·19 claims
- 3272US9629825B2Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoidGRUENENTHAL GMBH·Filed 2016·Granted Apr 25, 2017·1 cites·14 claims
- 3372US2020399226A13-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2020·Application pending·0 cites
- 3472US2020399280A13-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2020·Application pending·0 cites
- 3572US2020399255A18-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2020·Application pending·0 cites
- 3672US2021032256A13-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2020·Application pending·0 cites
- 3771US8357705B2Substituted cyclohexyldiaminesGRUENENTHAL GMBH·Filed 2009·Granted Jan 22, 2013·2 cites·7 claims
- 3871US2020399252A13-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL CHEMIE·Filed 2020·Application pending·0 cites
- 3970US10807989B23-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2019·Granted Oct 20, 2020·0 cites·31 claims
- 4070US10793528B23-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2019·Granted Oct 6, 2020·0 cites·34 claims
- 4169US9308196B2Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicamGRUENENTHAL GMBH·Filed 2013·Granted Apr 12, 2016·1 cites·9 claims
- 4268US8399503B2Spirocyclic azaindole derivativesZEMOLKA SASKIA·Filed 2009·Granted Mar 19, 2013·1 cites·11 claims
- 4367US8835689B2Substituted 4-aminocyclohexane derivativesNOLTE BERT·Filed 2012·Granted Sep 16, 2014·2 cites·6 claims
- 4467US2019106429A13-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 4567US2019106430A13-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 4667US2019100515A18-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 4767US2018273516A18-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 4867US2019100497A13-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 4965US2018201616A13-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane DerivativesGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 5065US2018282341A13-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Klaus Linz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →